Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Ferguson
William Walker

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 4, 2006
Developing a VATS lobectomy programme--can VATS lobectomy be taught?Jonathan Ferguson, William Walker
Edinburgh Medical Journal|April 13, 2018
On an Epidemic of Typhus in the North-West Provinces of IndiaWilliam Walker
Edinburgh Medical Journal|April 13, 2018
A Case of Diseased Cricoid CartilageWilliam Walker
Journal of Neural Transmission (Vienna, Austria : 1996)|January 19, 2013
Palliative care and end-of-life planning in Parkinson's diseaseRichard William Walker
Immunology|March 11, 2004
Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesisWilliam Walker, Dino Rotondo
Interactive Cardiovascular and Thoracic Surgery|February 9, 2010
Stake through the chestAmal K Bose, Jonathan Ferguson, Steven Hunter
Journal of the American Society for Mass Spectrometry|March 4, 2026
In Memory of Dr. Amina S. Woods: Visionary Mass Spectrometrist, Trailblazer in Molecular Neurobiology, and Devoted MentorScott Kuzdzal, Jonathan Ferguson, Shelley Jackson, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|September 10, 2019
Measurement of ambulatory venous pressure and column interruption duration in normal volunteersSeshadri Raju, William Walker, Corbin May
Cancers|March 13, 2024
Correction: Jannoo et al. Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide. <i>Cancers</i> 2023, <i>15</i>, 2772Riaz Jannoo, William Walker, Venkateswarlu Kanamarlapudi
Cancers|June 22, 2023
Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic PeptideRiaz Jannoo, William Walker, Venkateswarlu Kanamarlapudi
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 4, 2006
Developing a VATS lobectomy programme--can VATS lobectomy be taught?Jonathan Ferguson, William Walker
Edinburgh Medical Journal|April 13, 2018
On an Epidemic of Typhus in the North-West Provinces of IndiaWilliam Walker
Edinburgh Medical Journal|April 13, 2018
A Case of Diseased Cricoid CartilageWilliam Walker
Journal of Neural Transmission (Vienna, Austria : 1996)|January 19, 2013
Palliative care and end-of-life planning in Parkinson's diseaseRichard William Walker
Immunology|March 11, 2004
Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesisWilliam Walker, Dino Rotondo
Interactive Cardiovascular and Thoracic Surgery|February 9, 2010
Stake through the chestAmal K Bose, Jonathan Ferguson, Steven Hunter
Journal of the American Society for Mass Spectrometry|March 4, 2026
In Memory of Dr. Amina S. Woods: Visionary Mass Spectrometrist, Trailblazer in Molecular Neurobiology, and Devoted MentorScott Kuzdzal, Jonathan Ferguson, Shelley Jackson, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|September 10, 2019
Measurement of ambulatory venous pressure and column interruption duration in normal volunteersSeshadri Raju, William Walker, Corbin May
Cancers|March 13, 2024
Correction: Jannoo et al. Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide. <i>Cancers</i> 2023, <i>15</i>, 2772Riaz Jannoo, William Walker, Venkateswarlu Kanamarlapudi
Cancers|June 22, 2023
Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic PeptideRiaz Jannoo, William Walker, Venkateswarlu Kanamarlapudi
Pageof 10